Category: Medical
-
STAT+: Pharmalittle: We’re reading about FDA’s Prasad defending his plans, a Merck setback in Germany, and more
•
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
-
STAT+: Merck suffers a setback over its new Keytruda formulation in Germany
•
In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing…
-
STAT+: Vinay Prasad, FDA’s vaccine regulator, waves off criticism in closed-door remarks
•
NEW YORK — Vinay Prasad, the Food and Drug Administration’s top vaccines regulator, blamed “misleading media narratives” for…
-
STAT+: New data confirm Novo drug did not slow Alzheimer’s progression
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about FDA changes, a ‘discredited’ vaccine panel, and much more
•
Top of the morning to you, and a fine one it is, despite the gray skies hovering over…
-
STAT+: FDA to lower number of trials required for approval of drugs, other medical products
•
WASHINGTON — The Food and Drug Administration plans to begin requiring one clinical study, instead of the standard…
-
STAT+: FDA removes longtime over-the-counter drugs regulator from her position
•
WASHINGTON — The Food and Drug Administration removed the longtime director of the office of over-the-counter drugs from…
-
STAT+: Pharmalittle: We’re reading about FDA’s Pazdur retiring, Europe’s reaction to U.S.-U.K. pharma deal, and more
•
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and…
-
STAT+: Startup aims to combine AI with new small molecule technology
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Bristol to enroll more patients in key study of Cobenfy in Alzheimer’s psychosis
•
Bristol Myers Squibb said Wednesday it will enroll more patients in a key Phase 3 trial studying its…
-
STAT+: Top drug regulator Richard Pazdur set to leave FDA
•
WASHINGTON — Top drug regulator Richard Pazdur has filed papers to retire from the Food and Drug Administration…
-
STAT+: A drug that was ‘engineered with AI’ enters Phase 3 testing
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about hospitals suing to halt a 340B pilot, hepatitis B vaccine studies, and more
•
Good morning from Pharmalot’s Manhattan bureau. Jason Mast here filling in for Mr. Pharmalot. Today, I’m sipping on…
-
STAT+: Hospital groups sue the Trump administration to halt a 340B pilot program set to begin in January
•
The American Hospital Association and several large hospital systems have filed a lawsuit seeking to halt an upcoming…
-
STAT+: Top contributors to leading psychiatry journals fail to disclose industry payments, analysis finds
•
Amid ongoing concern over conflicts of interest that may affect medical practice, a new study found that 14%…
-
STAT+: U.K. pledges to boost pharma payments, will avoid U.S. tariffs on drugs
•
WASHINGTON — The United States and United Kingdom announced a high-level agreement Monday under which the U.K. is…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
